Some Ebola guidelines questioned

Experts questions questioning calls for suspending certain routine lab tests


Experts are questioning aspects of some of the Ebola guidelines that go beyond current Centers for Disease Control and Prevention (CDC) recommendations, especially those that call for suspending certain routine lab tests, according to an article on Infection Control Today.

A commentary in the journal Transfusion suggests that most individuals with suspected Ebola will have a fever due to another cause, and forgoing such testing may compromise patients' health more than any reduction in the risks to laboratory personnel.

The article says that all laboratory directors must work with infection control and safety experts to evaluate their hospital policies on potentially infectious patients to provide a safe environment.

Read the article.

 

 



December 12, 2014


Topic Area: Safety


Recent Posts

Ventilation and Filtering for Infection ControlĀ 

Poor IAQ can be deadly in healthcare facilities, so maintaining proper air conditioning and filter systems is key in controlling the spread of infection.


ChristianaCare Opens Aston Campus Neighborhood Hospital

The hospital is expected to care for approximately 15,000 patients each year.


Stantec Breaks Ground on New Academic Medical Center in Miami

The project is scheduled for completion in 2028.


Building Senior Living for the Next Generation of Retirees

As baby boomers seek new retirement expectations, developers and designers must rethink senior living facilities


Managing Drain and Biofilm Risk

Drains are out of sight, but a coordinated program linking infection prevention, EVS and facilities can keep them from getting out of control.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.